$3.88
-0.26-6.28%
Últ. Act.: Oct 19, 4:00 PM
$3.88
-0.26-6.28%
Treace Medical Concepts (TMCI) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Treace Medical Concepts (TMCI) publicó su última previsión de agosto 7, 2026 para fiscal year 2026. La compañía estimó ingresos en un rango de $204M - $212M para el período.
En comparación con la previsión anterior, Treace Medical Concepts mantenido redujo su previsión de ingresos desde un rango anterior de $202M - $212M.
Treace Medical Concepts ha emitido 24 actualizaciones de orientación entre el noviembre 8, 2022 y el agosto 7, 2026. During this period, the company raised its outlook 7 times and lowered it 7 times, providing investors with insight into management's evolving expectations.
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.30 | $-0.31 | $-0.14 | $-0.27 |
| Actual | $-0.24 | $-0.28 | $-0.15 | $-0.26 |
| Surprise | +20.0% | +9.68% | -7.14% | +3.70% |
| Revenue | ||||
| Estimate | $43.9M | $46.0M | $61.8M | $49.6M |
| Actual | $45.4M | $47.2M | $62.5M | $50.2M |
| Surprise | +3.34% | +2.54% | +1.12% | +1.25% |
| Metric | Q3 '26E | Q4 '26E |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Consensus | $-0.25 | $-0.10 |
| Revenue | ||
| Consensus | $47.7M | $67.4M |
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q2 | Aug 7, 2026 | $-0.24 | $-0.30 | 20.0 % |
| Q1 | May 8, 2026 | $-0.28 | $-0.31 | 9.68 % |
| Q4 | Feb 27, 2026 | $-0.15 | $-0.14 | -7.14 % |
| Q3 | Nov 6, 2025 | $-0.26 | $-0.27 | 3.70 % |
| Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
|---|---|---|---|---|
| Q2 | Aug 7, 2026 | $45.38M | $43.91M | 3.34 % |
| Q1 | May 8, 2026 | $47.20M | $46.03M | 2.54 % |
| Q4 | Feb 27, 2026 | $62.52M | $61.83M | 1.12 % |
| Q3 | Nov 6, 2025 | $50.21M | $49.59M | 1.25 % |